Publications by authors named "Finn Wisloff"

Claim this Profile
R
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma.
Ann Kristin Kvam, Peter M Fayers, Finn Wisloff

Eur J Haematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
Peter Gimsing, Kristina Carlson, Ingemar Turesson, Peter Fayers, Anders Waage

Lancet Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
Per Ole Iversen, Finn Wisløff, Nina Gulbrandsen

Clin Nutr· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma.
Ann K Kvam, Finn Wisløff, Peter M Fayers

Health Qual Life Outcomes· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study.
Ann K Kvam, Peter Fayers, Finn Wisloff

Eur J Haematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Close cooperation, but not oversteering].
Erlend B Smeland, Frode Vartdal, Finn Wisløff

Tidsskr Nor Laegeforen· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Leadership and academic competence].
Erlend B Smeland, Frode Vartdal, Finn Wisløff

Tidsskr Nor Laegeforen· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations.
Ann Kristin Kvam, Peter Fayers, Marianne Hjermstad, Nina Gulbrandsen, Finn Wisloff

Eur J Haematol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?].
Martin Aasbrenn, Frøydis Langmark, Finn Wisløff

Tidsskr Nor Laegeforen· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia.
Per Ole Iversen, Ekaterina Ukrainchenko, Boris Afanasyev, Kristin Hulbekkmo, Amal Choukah

Leuk Lymphoma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Research ethics and University of Oslo].
Haakon Breien Benestad, Finn Wisløff

Tidsskr Nor Laegeforen· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Epoetin in cancer treatment--the end of the game?].
Finn Wisløff

Tidsskr Nor Laegeforen· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
Monica Galli, Giovanna Borrelli, Eva Marie Jacobsen, Rosa Maria Marfisi, Guido Finazzi, Finn Wisloff

Blood· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum calcium is an independent predictor of quality of life in multiple myeloma.
Finn Wisløff, Ann Kristin Kvam, Martin Hjorth, Stig Lenhoff

Eur J Haematol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
Sigurd Liestøl, Per Morten Sandset, Eva Marie Jacobsen, Marie-Christine Mowinckel, Finn Wisløff

Br J Haematol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
Stig Lenhoff, Martin Hjorth, Ingemar Turesson, Jan Westin, Peter Gimsing

Haematologica· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines on the diagnosis and management of multiple myeloma 2005.
Alastair Smith, Finn Wisloff, Diana Samson, ,

Br J Haematol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene.
Eva M Jacobsen, Elin J Trettenes, Finn Wisløff, Ulrich Abildgaard

Thromb J· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antineoplastic agents targeting tyrosine kinases].
Tormod K Guren, Thoralf Christoffersen, G Hege Thoresen, Finn Wisløff, Olav Dajani

Tidsskr Nor Laegeforen· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.
Finn Wisløff, Nina Gulbrandsen, Martin Hjorth, Stig Lenhoff, Peter Fayers

Eur J Haematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
Sigurd Liestøl, Finn Wisløff

Thromb Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Mark A Crowther, Finn Wisloff

Thromb Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care.
Erik Hippe, Jan Westin, Finn Wislöff

Eur J Haematol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Total survival as quality indicator].
Finn Wisløff

Tidsskr Nor Laegeforen· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis